| Line Item | 2024-04-30 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $407K | -13.0% |
| SG&A Expense | $6.1M | +449.4% |
| Operating Income | -$8.5M | -32.0% |
| Income Tax | $0 | — |
| Net Income | $334K | +107.7% |
| EPS (Basic) | -$1.80 | -718.2% |
| EPS (Diluted) | -$1.80 | -718.2% |
| Line Item | 2024-04-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $50.2M | -26.2% |
| Short-term Investments | $0 | — |
| Current Assets | $50.4M | -26.0% |
| Total Assets | $59.9M | -18.3% |
| Current Liabilities | $7.4M | +1165.2% |
| Total Liabilities | $20.4M | +3376.0% |
| Stockholders' Equity | $27.6M | -62.0% |
| Line Item | 2024-04-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.2M | +43.3% |
| Investing Cash Flow | -$5.0M | — |
| Financing Cash Flow | -$10.7M | +21.0% |